Signaling Pathways - Androgen Receptor - 5-HT receptors - Insulin-like growth factors (IGFs) - NADPH Oxidases - RET
清除全部
-
B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂 -
B6326 Diphenyleneiodonium chloride中文名: 二苯基氯化碘盐Target: NADPH Oxidases|NOS|GPR3Summary: iNOS和eNOS抑制剂，GPR3激动剂 -
B3675 Apocynin中文名: 罗布麻宁，夹竹桃麻素，香兰基甲基酮Target: NADPH OxidasesSummary: 选择性NADPH氧化酶抑制剂 -
B2249 Lamotrigine1 Citation中文名: 拉莫三嗪Target: 5-HT receptors|sodium channelSummary: 5-HT抑制剂，钠通道阻断剂 -
A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂 -
A8364 ARN-5092 Citation中文名: 阿帕鲁胺Target: Androgen ReceptorSummary: 雄激素受体抑制剂 -
A2174 Lenvatinib (E7080)中文名: 乐伐替尼，仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂 -
A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂 -
A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂 -
A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂